You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gleevec

Showing 26 - 50 of 292
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sclerotic GVHD, Imatinib Mesylate Trial run by the NCI (Gleevec, STI571(Imatinib Mesylate))

Completed
Has Results
  • Sclerotic Graft Versus Host Disease
  • Imatinib Mesylate
  • Gleevec, STI571(Imatinib Mesylate)
  • Bethesda, Maryland
    National Cancer Institute (NCI), 9000 Rockville Pike
Mar 27, 2020

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Unspecified Adult Solid Tumor Trial in San Francisco (bevacizumab, cyclophosphamide, imatinib)

Completed
  • Unspecified Adult Solid Tumor
  • bevacizumab
  • +2 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Jul 24, 2020

Lymphangioleiomyomatosis Trial in New York, Charleston (Imatinib Mesylate 400Mg Capsule, Placebo - Capsule)

Completed
Has Results
  • Lymphangioleiomyomatosis
  • Imatinib Mesylate 400Mg Capsule
  • Placebo - Capsule
  • New York, New York
  • +1 more
Jun 4, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jan 6, 2021

Rare Tumor Trial (Almonertinib 110 MG, Dacomitinib 45 MG, Alectinib 150 MG)

Not yet recruiting
  • Rare Tumor
  • Almonertinib 110 MG
  • +10 more
  • (no location specified)
Jul 31, 2020

Leukemia Trial in Los Angeles (dasatinib)

Completed
  • Leukemia
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Leukemia Trial in Buffalo, Durham, Cleveland (drug, genetic, other, procedure)

Completed
Has Results
  • Leukemia
  • imatinib mesylate
  • +5 more
  • Buffalo, New York
  • +3 more
Mar 4, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,

Completed
Has Results
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2020

GVHD Trial in Stanford, Seattle (Imatinib)

Completed
  • Graft vs Host Disease
  • Stanford, California
  • +1 more
Apr 13, 2020

Pulmonary Veno Occlusive Disease Trial in Boston (Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Pulmonary Veno Occlusive Disease
  • Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
  • Boston, Massachusetts
    Boston Childrens Hospital
Jun 6, 2019

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Colonic Tumors Trial in Amersfoort, Utrecht (Imatinib)

Terminated
  • Colonic Neoplasms
  • Amersfoort, Utrecht, Netherlands
  • +2 more
Oct 9, 2019

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Gastrointestinal Stromal Tumor (GIST) Trial in United States (AT13387 and Imatinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • AT13387 and Imatinib
  • Tucson, Arizona
  • +7 more
Jan 13, 2020

Diabetes, Type I, Diabetes, Insulin-Dependent, 1, Type 1 Diabetes Trial in Australia, United States (Imatinib Mesylate, Placebo

Completed
Has Results
  • Diabetes Mellitus, Type I
  • +4 more
  • Imatinib Mesylate
  • Placebo (For imatinib mesylate)
  • San Francisco, California
  • +8 more
Feb 10, 2020

Pulmonary Arterial Hypertension Trial in Adelaide (AER-901 Solution for Nebulization, Placebo)

Recruiting
  • Pulmonary Arterial Hypertension
  • AER-901 Solution for Nebulization
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX
Feb 14, 2022

Chronic Myelogenous Leukemia Trial in Houston (Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelogenous Leukemia
  • Lonafarnib (SCH66336)
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    M.D. Anderson Cancer Center
Nov 6, 2018

GIST and CML Trial in Worldwide (imatinib mesylate)

Active, not recruiting
  • GIST and CML
  • imatinib mesylate
  • Los Angeles, California
  • +28 more
Apr 25, 2022

Chronic Myelogenous Leukemia Patients Treated With Imatinib

Recruiting
  • Chronic Myelogenous Leukemia
  • Chart Review
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 8, 2022

Myelogenous Leukemia, Chronic, Chronic Phase Trial in Houston (Gleevec)

Terminated
Has Results
  • Myelogenous Leukemia, Chronic, Chronic Phase
  • Gleevec
  • Houston, Texas
    MD Anderson Cancer Center
Sep 11, 2018

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Osteosarcoma Trial (Vactosertib)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Oct 18, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Imatinib mesylate)

Completed
  • Chronic Myeloid Leukemia
  • Imatinib mesylate
  • MontrĂ©al, Quebec, Canada
  • +13 more
Nov 28, 2019